These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24652744)

  • 41. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generating tolerogenic dendritic cells with neuropeptides.
    Delgado M
    Hum Immunol; 2009 May; 70(5):300-7. PubMed ID: 19405171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?
    Lutz MB; Schuler G
    Trends Immunol; 2002 Sep; 23(9):445-9. PubMed ID: 12200066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells.
    Yogev N; Frommer F; Lukas D; Kautz-Neu K; Karram K; Ielo D; von Stebut E; Probst HC; van den Broek M; Riethmacher D; Birnberg T; Blank T; Reizis B; Korn T; Wiendl H; Jung S; Prinz M; Kurschus FC; Waisman A
    Immunity; 2012 Aug; 37(2):264-75. PubMed ID: 22902234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcriptional determinants of tolerogenic and immunogenic states during dendritic cell maturation.
    Vander Lugt B; Riddell J; Khan AA; Hackney JA; Lesch J; DeVoss J; Weirauch MT; Singh H; Mellman I
    J Cell Biol; 2017 Mar; 216(3):779-792. PubMed ID: 28130292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The benefits of diversity: heterogenous DC populations allow for both immunity and tolerance.
    Moore JR
    J Theor Biol; 2014 Sep; 357():86-102. PubMed ID: 24816181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell-extrinsic CTLA4-mediated regulation of dendritic cell maturation depends on STAT3.
    Kowalczyk A; D'Souza CA; Zhang L
    Eur J Immunol; 2014 Apr; 44(4):1143-55. PubMed ID: 24338929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship.
    Mahnke K; Johnson TS; Ring S; Enk AH
    J Dermatol Sci; 2007 Jun; 46(3):159-67. PubMed ID: 17428639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of tolerogenic DCs: 'you are what you eat'.
    Mahnke K; Knop J; Enk AH
    Trends Immunol; 2003 Dec; 24(12):646-51. PubMed ID: 14644138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Revisiting Current Concepts on the Tolerogenicity of Steady-State Dendritic Cell Subsets and Their Maturation Stages.
    Lutz MB; Backer RA; Clausen BE
    J Immunol; 2021 Apr; 206(8):1681-1689. PubMed ID: 33820829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CCL18 differentiates dendritic cells in tolerogenic cells able to prime regulatory T cells in healthy subjects.
    Azzaoui I; Yahia SA; Chang Y; Vorng H; Morales O; Fan Y; Delhem N; Ple C; Tonnel AB; Wallaert B; Tsicopoulos A
    Blood; 2011 Sep; 118(13):3549-58. PubMed ID: 21803856
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-155 Upregulation in Dendritic Cells Is Sufficient To Break Tolerance In Vivo by Negatively Regulating SHIP1.
    Lind EF; Millar DG; Dissanayake D; Savage JC; Grimshaw NK; Kerr WG; Ohashi PS
    J Immunol; 2015 Nov; 195(10):4632-40. PubMed ID: 26447227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenic, but not steady-state, antigen presentation permits regulatory T-cells to control CD8+ T-cell effector differentiation by IL-2 modulation.
    McNally A; McNally M; Galea R; Thomas R; Steptoe RJ
    PLoS One; 2014; 9(1):e85455. PubMed ID: 24454872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How tolerogenic dendritic cells induce regulatory T cells.
    Maldonado RA; von Andrian UH
    Adv Immunol; 2010; 108():111-65. PubMed ID: 21056730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of dendritic cell by pathogen antigens: Where do we stand?
    Peron G; de Lima Thomaz L; Camargo da Rosa L; Thomé R; Cardoso Verinaud LM
    Immunol Lett; 2018 Apr; 196():91-102. PubMed ID: 29427742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homeostatic NF-κB Signaling in Steady-State Migratory Dendritic Cells Regulates Immune Homeostasis and Tolerance.
    Baratin M; Foray C; Demaria O; Habbeddine M; Pollet E; Maurizio J; Verthuy C; Davanture S; Azukizawa H; Flores-Langarica A; Dalod M; Lawrence T
    Immunity; 2015 Apr; 42(4):627-39. PubMed ID: 25862089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Processing and presentation of antigens by dendritic cells: implications for vaccines.
    Bhardwaj N
    Trends Mol Med; 2001 Sep; 7(9):388-94. PubMed ID: 11530333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antigen delivery to dendritic cells shapes human CD4+ and CD8+ T cell memory responses to Staphylococcus aureus.
    Uebele J; Stein C; Nguyen MT; Schneider A; Kleinert F; Tichá O; Bierbaum G; Götz F; Bekeredjian-Ding I
    PLoS Pathog; 2017 May; 13(5):e1006387. PubMed ID: 28542586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variegated Outcomes of T Cell Activation by Dendritic Cells in the Steady State.
    Bourque J; Hawiger D
    J Immunol; 2022 Feb; 208(3):539-547. PubMed ID: 35042789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.